Combination Immunotherapy for High-Risk Resected and Metastatic Melanoma Patients

BACKGROUND: Patients with advanced melanoma have a poor outcome. We hypothesize that combination immunotherapy can synergistically activate host immunity to generate an effective treatment for patients with high-risk, resected stage 3, recurrent, refractory, or stage 4 melanoma. METHODS: We conducte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Riker, Adam I., Rossi, Gabriela R., Masih, Prerna, Alsfeld, L. C., Denham, Fiona, Tennant, Lucinda, Ramsey, W. Jay, Vahanian, Nicholas N., Link, Charles J.
Formato: Artigo
Idioma:Inglês
Publicado em: the Academic Division of Ochsner Clinic Foundation 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4052581/
https://ncbi.nlm.nih.gov/pubmed/24940124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados